TMCI Treace Medical Concepts, Inc.

Fundamentals / CIK 0001630627 / USD

Treace Medical Concepts, Inc. reported $203.3M in revenue and a net loss of $55.79M for the trailing twelve months ended September 30, 2026 (down 3.9% year over year), with a 79.6% gross margin and a -24.4% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open TMCI in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

7 fiscal years (2019 to 2025), reported in USD.

$215.9M$107.9M$0-$73.25MFY 2019 Revenue: $39.42MFY 2019 Net Income: -$4.26M2019FY 2020 Revenue: $57.37MFY 2020 Net Income: -$3.67M2020FY 2021 Revenue: $94.42MFY 2021 Net Income: -$20.55M2021FY 2022 Revenue: $141.8MFY 2022 Net Income: -$42.81M2022FY 2023 Revenue: $187.1MFY 2023 Net Income: -$49.53M2023FY 2024 Revenue: $209.4MFY 2024 Net Income: -$55.74M2024FY 2025 Revenue: $212.7MFY 2025 Net Income: -$59.00M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $212.7M $209.4M $187.1M $141.8M $94.42M $57.37M $39.42M
Cost of Revenue $42.94M $41.09M $35.18M $25.53M $16.89M $12.47M $7.63M
Gross Profit $169.8M $168.3M $151.9M $116.3M $77.53M $44.90M $31.79M
Research & Development $20.28M $20.59M $15.44M $13.58M $10.20M $5.85M $5.07M
Selling, General & Admin $203.6M $203.4M $187.9M $137.6M $83.84M $38.19M $30.25M
Total Operating Expenses $223.9M $224.0M $203.4M $151.2M $94.04M $44.04M $35.32M
Operating Income -$54.15M -$55.69M -$51.43M -$34.84M -$16.51M $855K -$3.54M
EBITDA -$43.53M -$47.27M -$46.08M -$32.71M -$15.82M $2.06M -$2.74M
Interest Expense $5.32M $5.26M $5.17M $4.40M $4.06M $2.78M $841K
Income Tax Expense $0 $0 $0 $0 $0 $0 $0
Net Income -$59.00M -$55.74M -$49.53M -$42.81M -$20.55M -$3.67M -$4.26M
Basic EPS -$0.93 -$0.90 -$0.81 -$0.77 -$0.43 -$0.12 -$0.13
Diluted EPS -$0.93 -$0.90 -$0.81 -$0.77 -$0.43 -$0.12 -$0.13
Basic Shares Outstanding 63.3M 62.1M 60.9M 55.3M 48.4M 37.1M 36.9M
Diluted Shares Outstanding 63.3M 62.1M 60.9M 55.3M 48.4M 37.1M 36.9M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $48.25M $45.38M $47.20M $62.52M $50.21M $47.39M $52.57M $68.71M
Cost of Revenue $9.90M $9.77M $9.79M $12.12M $10.51M $9.63M $10.68M $13.23M
Gross Profit $38.35M $35.61M $37.41M $50.40M $39.71M $37.75M $41.89M $55.48M
Research & Development $4.49M $4.38M $4.62M $4.54M $4.68M $5.50M $5.56M $5.21M
Selling, General & Admin $45.39M $46.19M $49.95M $51.78M $50.70M $49.23M $51.91M $50.47M
Total Operating Expenses $49.88M $50.56M $54.57M $56.32M $55.38M $54.73M $57.48M $55.68M
Operating Income -$11.53M -$14.96M -$17.17M -$5.92M -$15.68M -$16.97M -$15.58M -$204K
EBITDA -$9.50M -$13.07M -$16.27M -$3.11M -$12.90M -$14.40M -$13.12M $2.03M
Interest Expense $1.58M $1.56M $1.57M $1.35M $1.34M $1.32M $1.31M $1.31M
Net Income -$12.57M -$15.87M -$17.96M -$9.39M -$16.29M -$17.40M -$15.92M -$501K
Basic EPS -$0.19 -$0.24 -$0.28 -- -$0.26 -$0.28 -$0.25 --
Diluted EPS -$0.19 -$0.24 -$0.28 -- -$0.26 -$0.28 -$0.25 --
Basic Shares Outstanding 65.5M 65.0M 64.6M -- 63.5M 63.0M 62.7M --
Diluted Shares Outstanding 65.5M 65.0M 64.6M -- 63.5M 63.0M 62.7M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $10.71M $11.35M $12.98M $19.47M $105.8M $18.08M
Short-Term Investments $37.66M $64.33M $110.2M $61.78M $0 --
Cash & Short-Term Investments $48.37M $75.68M $123.2M $81.25M $105.8M $18.08M
Accounts Receivable, Net $42.16M $40.80M $38.10M $29.20M $18.57M $14.49M
Inventory $36.03M $39.26M $29.25M $19.33M $10.56M $7.82M
Total Current Assets $132.1M $161.4M $198.4M $133.4M $138.0M $40.98M
Property, Plant & Equipment, Net $29.75M $25.95M $22.30M $15.34M $2.85M $829K
Goodwill $12.81M $12.81M $12.81M $0 -- --
Intangible Assets $7.12M $8.07M $9.03M $0 -- --
Other Non-Current Assets $1.22M $407K $146K $146K $0 --
Total Non-Current Assets $58.53M $55.69M $53.55M $25.62M $2.85M $829K
Total Assets $190.6M $217.1M $251.9M $159.0M $140.8M $41.81M
Accounts Payable $6.73M $10.52M $11.84M $8.67M $4.06M $2.27M
Short-Term Debt $1.75M $0 -- -- -- $1.79M
Total Current Liabilities $30.64M $34.92M $45.03M $30.25M $18.21M $11.60M
Long-Term Debt $55.58M $53.31M $53.01M $52.71M $29.36M $29.19M
Other Non-Current Liabilities $3.05M $37K $37K $0 -- --
Total Non-Current Liabilities $72.61M $69.28M $68.94M $68.25M $29.54M $29.43M
Total Liabilities $103.2M $104.2M $114.0M $98.50M $47.75M $41.03M
Total Debt (incl. Leases) $71.86M $69.65M $70.30M $68.59M $29.36M $30.98M
Common Stock $64K $62K $62K $55K $45K --
Retained Earnings -$249.0M -$190.0M -$134.2M -$84.72M -$41.91M -$21.35M
Accumulated Other Comp. Income $72K $97K $163K -$27K $0 --
Total Stockholders' Equity $87.33M $112.9M $137.9M $60.53M $93.07M $776K
Total Equity $87.33M $112.9M $137.9M $60.53M $93.07M $776K

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $7.76M $12.61M $9.54M $10.71M $7.69M $8.05M $13.37M $11.35M
Short-Term Investments $32.04M $33.01M $42.31M $37.66M $49.73M $61.24M $62.72M $64.33M
Cash & Short-Term Investments $39.80M $45.62M $51.85M $48.37M $57.42M $69.29M $76.09M $75.68M
Accounts Receivable, Net $30.22M $28.73M $30.36M $42.16M $32.96M $30.33M $31.11M $40.80M
Inventory $42.30M $39.54M $36.37M $36.03M $41.42M $42.40M $37.94M $39.26M
Total Current Assets $118.7M $120.5M $123.5M $132.1M $138.0M $147.6M $149.4M $161.4M
Property, Plant & Equipment, Net $33.04M $32.50M $32.06M $29.75M $29.97M $29.71M $27.13M $25.95M
Goodwill $12.81M $12.81M $12.81M $12.81M $12.81M $12.81M $12.81M $12.81M
Intangible Assets $6.41M $6.65M $6.89M $7.12M $7.36M $7.60M $7.84M $8.07M
Other Non-Current Assets $1.43M $1.50M $1.50M $1.22M $614K $676K $387K $407K
Total Non-Current Assets $60.61M $60.60M $60.63M $58.53M $58.59M $58.84M $56.41M $55.69M
Total Assets $179.3M $181.1M $184.1M $190.6M $196.6M $206.4M $205.8M $217.1M
Accounts Payable $14.28M $16.06M $13.54M $6.73M $16.10M $19.96M $13.22M $10.52M
Short-Term Debt $3.78M $3.17M $1.78M $1.75M $1.80M $1.11M $45K $0
Total Current Liabilities $46.08M $41.50M $34.49M $30.64M $40.91M $41.90M $33.18M $34.92M
Long-Term Debt $56.26M $56.04M $55.82M $55.58M $53.53M $53.45M $53.38M $53.31M
Other Non-Current Liabilities $2.69M $2.69M $3.05M $3.05M $37K $37K $37K $37K
Total Non-Current Liabilities $71.58M $71.82M $72.42M $72.61M $66.50M $66.93M $67.33M $69.28M
Total Liabilities $117.7M $113.3M $106.9M $103.2M $107.4M $108.8M $100.5M $104.2M
Total Debt (incl. Leases) $74.48M $72.69M $71.60M $71.86M $70.37M $70.09M $69.36M $69.65M
Common Stock $66K $65K $65K $64K $64K $63K $63K $62K
Retained Earnings -$295.4M -$282.8M -$267.0M -$249.0M -$239.6M -$223.3M -$205.9M -$190.0M
Accumulated Other Comp. Income -$108K -$52K -$26K $72K $83K $50K $57K $97K
Total Stockholders' Equity $61.65M $67.74M $77.19M $87.33M $89.19M $97.61M $105.3M $112.9M
Total Equity $61.65M $67.74M $77.19M $87.33M $89.19M $97.61M $105.3M $112.9M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$59.00M -$55.74M -$49.53M -$42.81M -$20.55M -$3.67M -$4.26M
Depreciation & Amortization $10.62M $8.42M $5.35M $2.13M $685K $1.21M $793K
Stock-Based Compensation $33.82M $30.60M $17.35M $8.11M $3.41M $919K $815K
Change in Receivables -$2.09M -$5.69M -$9.30M -$11.04M -$4.23M -$4.29M -$6.02M
Change in Inventory $3.22M -$10.01M -$9.85M -$8.77M -$2.74M -$2.26M -$2.81M
Change in Payables -$3.80M -$1.31M $3.17M $4.61M $1.79M $1.33M -$236K
Operating Cash Flow -$15.97M -$37.17M -$34.58M -$30.65M -$17.19M -$4.49M -$7.67M
Capital Expenditure -$13.52M -$11.59M -$11.46M -$14.84M -$2.71M -$1.07M -$1.21M
Free Cash Flow -$29.49M -$48.76M -$46.03M -$45.49M -$19.90M -$5.56M -$8.88M
Acquisitions, Net $0 $0 -$20.00M $0 $0 -- --
Purchases of Investments -$40.57M -$71.58M -$169.9M -$63.41M $0 $0 --
Investing Cash Flow $13.25M $35.38M -$81.30M -$76.52M -$2.71M -$1.07M -$1.21M
Financing Cash Flow $2.08M $160K $109.4M $20.81M $107.7M $11.50M $19.74M
Net Change in Cash -$642K -$1.63M -$6.49M -$86.36M $87.75M $5.94M $10.86M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$12.57M -$15.87M -$17.96M -$9.39M -$16.29M -$17.40M -$15.92M -$501K
Depreciation & Amortization $2.03M $1.89M $899K $2.81M $2.78M $2.58M $2.46M $2.24M
Stock-Based Compensation $6.93M $6.46M $8.03M $7.55M $8.00M $9.58M $8.69M $8.55M
Change in Receivables -$1.61M $1.50M $11.69M -$9.52M -$2.56M $696K $9.29M -$17.19M
Change in Inventory -$2.76M -$3.18M -$335K $5.39M $973K -$4.46M $1.31M $4.36M
Change in Payables -$1.78M $2.52M $6.81M -$9.38M -$3.86M $6.74M $2.70M -$8.13M
Operating Cash Flow -$3.25M -$4.70M $7.24M -$8.03M -$9.09M -$3.05M $4.20M -$4.21M
Capital Expenditure -$2.17M -$2.20M -$3.06M -$2.40M -$2.81M -$4.77M -$3.54M -$3.07M
Free Cash Flow -$5.43M -$6.90M $4.18M -$10.42M -$11.90M -$7.82M $655K -$7.28M
Purchases of Investments -$7.51M -$2.60M -$16.07M -$5.68M -$4.64M -$15.16M -$15.09M -$18.69M
Investing Cash Flow -$1.26M $7.07M -$7.82M $9.67M $8.74M -$3.26M -$1.89M $3.42M
Financing Cash Flow -$335K $696K -$588K $1.38M -$10K $987K -$282K $26K
Net Change in Cash -$4.85M $3.07M -$1.16M $3.02M -$366K -$5.32M $2.02M -$760K

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Gross Margin 79.8% 80.4% 81.2% 82.0% 82.1% 78.3% 80.6%
Operating Margin -25.5% -26.6% -27.5% -24.6% -17.5% 1.5% -9.0%
Net Profit Margin -27.7% -26.6% -26.5% -30.2% -21.8% -6.4% -10.8%
Return on Equity (ROE) -67.6% -49.4% -35.9% -70.7% -22.1% -472.7% --
Return on Assets (ROA) -31.0% -25.7% -19.7% -26.9% -14.6% -8.8% --
Current Ratio 4.31x 4.62x 4.40x 4.41x 7.58x 3.53x --
Quick Ratio 3.13x 3.50x 3.76x 3.77x 7.00x 2.86x --
Debt to Equity 0.82x 0.62x 0.51x 1.13x 0.32x 39.92x --
Revenue Growth (YoY) +1.6% +11.9% +31.9% +50.2% +64.6% +45.5% --
Gross Profit Growth (YoY) +0.9% +10.7% +30.6% +50.0% +72.7% +41.2% --
Operating Income Growth (YoY) -- -- -- -- -2031.0% -- --
5Y Revenue / Share Growth +117.2% +215.6% -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Gross Margin 79.6% 79.5% 79.7% 79.8% 79.9% 80.1% 80.2% 80.4%
Operating Margin -24.4% -26.2% -26.9% -25.5% -22.1% -22.4% -24.8% -26.6%
Net Profit Margin -27.4% -29.0% -29.4% -27.7% -22.9% -23.0% -25.1% -26.6%
Return on Equity (ROE) -90.5% -87.9% -79.1% -67.6% -56.2% -50.4% -50.3% -49.4%
Return on Assets (ROA) -31.1% -32.9% -33.2% -31.0% -25.5% -23.8% -25.7% -25.7%
Current Ratio 2.58x 2.90x 3.58x 4.31x 3.37x 3.52x 4.50x 4.62x
Quick Ratio 1.66x 1.95x 2.53x 3.13x 2.36x 2.51x 3.36x 3.50x
Debt to Equity 1.21x 1.07x 0.93x 0.82x 0.79x 0.72x 0.66x 0.62x
Revenue Growth (YoY) -3.9% -4.2% -10.2% -9.0% +11.4% +6.6% +2.9% +10.4%
Gross Profit Growth (YoY) -3.4% -5.7% -10.7% -9.1% +9.9% +5.8% +2.2% +9.3%
Operating Cash Flow Growth (YoY) -- -- +72.5% -- -- -- -- -890.8%
Free Cash Flow Growth (YoY) -- -- +537.9% -- -- -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0001630627) · from December 31, 2019 Data through September 30, 2026 · synced Nov 20, 2026, 05:39 UTC · Open in terminal